[HTML][HTML] Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer

RL Bitting, AJ Armstrong - Endocrine-related cancer, 2013 - erc.bioscientifica.com
Prostate and breast cancer are the two cancers with the highest incidence in men and
women, respectively. Here, we focus on the known biology of acquired resistance to …

Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer

RL Bitting, AJ Armstrong - Endocrine-Related Cancer, 2013 - hero.epa.gov
Abstract The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin
(mTOR) pathway is a key signaling pathway that has been linked to both tumorigenesis and …

Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer.

RL Bitting, AJ Armstrong - Endocrine-related Cancer, 2013 - europepmc.org
The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR)
pathway is a key signaling pathway that has been linked to both tumorigenesis and …

Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer

RL Bitting, AJ Armstrong - Endocrine-Related Cancer, 2013 - cir.nii.ac.jp
抄録< jats: p> The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin
(mTOR) pathway is a key signaling pathway that has been linked to both tumorigenesis and …

Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer

RL Bitting, AJ Armstrong - Endocrine-related cancer, 2013 - pubmed.ncbi.nlm.nih.gov
The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR)
pathway is a key signaling pathway that has been linked to both tumorigenesis and …

[PDF][PDF] Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer

RL Bitting, AJ Armstrong - Endocrine-Related Cancer, 2013 - scholar.archive.org
Abstract The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin
(mTOR) pathway is a key signaling pathway that has been linked to both tumorigenesis and …